MTEM News and Press, Molecular Templates Inc. From 11/02/23

AUSTIN, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today ann...

AUSTIN, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineer...

2023-09-29 03:25:36 ET More on Molecular Templates Molecular Templates announces executive leadership changes Molecular Templates launches $40M private placement Seeking Alpha’s Quant Rating on Molecular Templates Historical earnings data for Molecular...

AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today an...

AUSTIN, Texas, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) (the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, today announced that the Board and stock...

2023-08-10 11:05:17 ET Molecular Templates press release ( NASDAQ: MTEM ): Q2 GAAP EPS of -$0.19 beats by $0.15 . Revenue of $6.87M (+55.4% Y/Y) beats by $4.29M . For further details see: Molecular Templates GAAP EPS of -$0.19 beats by $0.15, revenue of $...

AUSTIN, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineer...

2023-08-02 16:39:37 ET Molecular Templates ( NASDAQ: MTEM ) Inc on Wednesday announced Gabriela Gruia will assume the role of interim Chief Medical Officer to succeed Roger Waltzman, while Jason Kim will assume the role of President and CFO. Kristen Quigley, who ...

Dr. Gabriela Gruia to assume the role of interim Chief Medical Officer Jason Kim to assume the role of President and Chief Financial Officer Kristen Quigley to assume the role of Chief Operating Officer Dr. Grace Kim to assume the role of Chief Strategy Officer and Head of...

2023-07-13 09:09:03 ET Molecular Templates ( NASDAQ: MTEM ) plans to conduct a private placement offering of securities to raise up to $40 million, the company said Thursday. Certain healthcare investors participating in the offering will purchase an initial tranche of $20 mil...